Insider Selling: West Pharmaceutical Services CFO Unloads 38,366 Shares of Stock (WST)
West Pharmaceutical Services (NYSE:WST) CFO William J. Federici sold 38,366 shares of the stock on the open market in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $42.56, for a total value of $1,632,856.96. Following the transaction, the chief financial officer now directly owns 205,460 shares in the company, valued at approximately $8,744,378. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of West Pharmaceutical Services (NYSE:WST) traded up 0.16% on Thursday, hitting $44.01. The stock had a trading volume of 207,759 shares. West Pharmaceutical Services has a 52 week low of $36.77 and a 52 week high of $51.12. The stock’s 50-day moving average is $41.18 and its 200-day moving average is $43.32. The company has a market cap of $3.114 billion and a price-to-earnings ratio of 27.77.
West Pharmaceutical Services (NYSE:WST) last released its earnings data on Thursday, July 31st. The company reported $0.52 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter in the prior year, the company posted $0.86 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Analysts expect that West Pharmaceutical Services will post $1.84 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, November 5th. Investors of record on Wednesday, October 22nd will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 1.00%.
Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.
West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.